Crossbow Therapeutics develops immunotherapies that focus on engineering immune cells to target disease-specific antigens. The company builds platforms that combine antibody discovery with cell therapy approaches to direct immune responses toward cancer cells. Its work involves designing molecules that guide immune cells to recognize and eliminate